期刊文献+

CD147与基质金属蛋白酶-2,3,9在卵巢癌中的表达及临床病理意义 被引量:8

Expressions of MMP-2,MMP-3,MMP-9 and CD147 in human ovarian cancer and their clinicopathological significance
下载PDF
导出
摘要 目的:检测CD147和基质金属蛋白酶(MMP)-2,3,9在卵巢癌中的表达,了解其与卵巢癌临床病理特征之间的关系,探讨卵巢癌中CD147与MMP-2、MMP-3和MMP-9表达的相关性。方法:用免疫组化SP法对40例卵巢癌组织,9例良性卵巢上皮性肿瘤组织中CD147和MMP-2、MMP-3、MMP-9的表达情况进行检测。结果:CD147和MMP-2、MMP-3及MMP-9在卵巢癌中的阳性表达率分别为92.5%,100%,100%和95%,阳性表达与病理分级和临床分期有关(P<0.05),与组织学类型无关,与临床预后无显著相关(P>0.05)。在卵巢癌中,CD147与MMP-2、MMP-3和MMP-9多同时表达,呈现出显著正相关,相关系数分别为0.802,0.786,0.914(P<0.001)。结论:卵巢癌组织中CD147、MMP-2、MMP-3及MMP-9的表达与的临床分期及病理分级有关。MMP-2、MMP-3和MMP-9的分泌增加可能与CD147的诱导促进作用有关系。 Objective:To investigate the expressions of MMP-2,MMP-3,MMP-9 and CD147 in human ovarian cancer and their clinicopathological significance. Methods:Immunohisto chemical S-P method was performed to detect the expressions of MMP-2,MMP-3,MMP-9,CD147 in 40 malignant and 9 benign ovarian tumors. Result:The expression rates of MMP-2, MMP-3,MMP-9 and CD147 in ovarian cancer were 92.5%,100%,100% and 95%,respectively. The expressions of MMP-2, MMP-3,MMP-9 and CD147 in ovarian cancer were related with clinical stage and pathological garade (P〈0.05) but not with the histological type and clinical prognosis (P〉0.05). There were positive correlations between the expressions of CD147 and MMP-2,MMP-3,MMP-9 (r=0.802,0.786,0.914)in ovarian cancer. Conclusion:Expressions of CD147,MMP-2,MMP-3 and MMP-9 have relevance to clinical stages and pathological grades in ovarian cancer,and overexpression of CD147 may induce the secretion of MMP-2,MMP-3,MMP-9.
出处 《重庆医科大学学报》 CAS CSCD 2007年第11期1165-1168,1184,共5页 Journal of Chongqing Medical University
关键词 CD147 基质金属蛋白酶-2 基质金属蛋白酶-3 基质金属蛋白酶-9 卵巢癌 免疫组化 CD147 Matrix metalloproteinase-9 Matrix metalloproteinase-2 Matrix metalloproteinase-3 Ovarian cancer Immuno- histochemistry
  • 相关文献

参考文献13

  • 1Westerlund A,Hujanen E,Puistola U,et al. Fibroblasts stimulate human ovarian cancer cell invasion and expression of 72-kDa gelatinase A (MMP-2)[J]. Gynecol Oncol, 1997 ; 67( 1 ) : 76-82.
  • 2Kim TS,Kim YB. Correlation between expression of matrix metalloproteinase-2(MMP-2),and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma[J]. Krean Med Sci,1999; 14(3): 263-270.
  • 3Nabeshima K,Iwasaki H,Koga K,et al. Emmprin (basigin/CD147): Matrix metallo-proteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression[J]. Pathology International, 2006; 6 (7):359-367.
  • 4蔡威,宋今丹.基质金属蛋白酶及其组织抑制物在卵巢肿瘤中的表达[J].癌症,2002,21(1):91-94. 被引量:29
  • 5Hanemaaijer R,Verheijen J. Matrix metalloproteinase inhibitors: current developments and future perspective[J]. The Oncologist, 2001; 6:415--427.
  • 6Sato H,Kida Y,Mai M,et al. Expression of genes encoding type Ⅳ collagendygrading metalloproteinases and tissue inhibitors of metalloproteinases on various human tumor cells[J]. Oncogene, 1999; 7 : 77-85.
  • 7Bernhard EJ,Gruber SB,Muschel RJ,et al. Direct evidence linging expression of matrix metalloproteinase 9 (98-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells[J]. Proc Natl Acad Sci USA,1994;91:4293-4297.
  • 8Mayr D,Kanitz V,Anderegg B,et al. Analysis of gene amplification and prognostic markers in ovarian cancer using comparative genomic hybridization for microarrays and immunohistochemical analysis for tissue microarrays[J]. Am J Clin Pathol,2006;126(1): 101-109.
  • 9Guo H,Li R,Zucker S,et al. EMMPRIN (CD147),an inducer of matrix metalloproteinase synthesis,also binds interstitial collagenase to the tumor cell surface[J]. Cancer Res, 2000; 60(4) : 888-891.
  • 10Decastro R,hang Y,Guo H,et al. Human kerationcytes express EMMPRIN,an extracellular matrix metalloproteinase inducer[J]. J Invest Dermatol, 1996 ;06 (6) : 2160-2165.

二级参考文献13

  • 1龚涌灵 许国铭.人胰腺癌中细胞外基质蛋白的分子生物学意义[J].国外医学:肿瘤学分册,1997,:270-270.
  • 2Kachra Z,Beaulieu E,Delbecchi L,et al.Expression of matrix metalloproteinaes and their inhibitors in human brain tumors [J].Clin Exp metastasis,1999,17: 555-566.
  • 3Liotta LA,Stetler-Stevenson WG.Tumor invasion and metastasis: an imbalance of positive and negative regulation [J].Cancer Res (suppl),1991,51: 5054s-5059s.
  • 4Campo E,Merino MJ,Tavassoli FA,et al.Evaluation of basement membrane components and the 72 000 kDa type Ⅵ collagenase in serous tumors of the ovary [J].Am J Surg Pathol,1992,16: 500-507.
  • 5Autio-Harmainen H,Karttunen T,Hurskainen T,et al.Expression of 72 kilodalton type collagenase (Gelatinase A) in benign and malignant ovarian tumors [J].Lab Invest,1993,69: 312-321.
  • 6Furuya M,Ishikura H,Kawarada Y,et al.Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms [J].Gynecol Oncol,2000,78: 106-112.
  • 7Dolo V,D Ascenzo S,Violoni S,et al.Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer in vivo and in vitro [J].Clin Exp Metastasis,1999,17: 131-140.
  • 8ontgomery AMP,Mueller BM,Reisfeld RA,et al.Effect of tissue inhibitor of the matrix metalloproteinase-2 expression on the growth and spontaneous metastasis of a human melanoma cell line[J].Cancer Res,1994,54: 5467-5473.
  • 9Murphy AN,Unsworth EJ,Stetler-Stevenson WG.Tissue inhibitor of metalloproteinase-2 inhibitors bFCF-induced human microvascular endothelial cell proliferation [J].J Cell Physiol,1993,157: 351-358.
  • 10Ylisirni S,H yhty M,Turpeenniemi-Hujanen T.Serum matrix metalloproteinases-2,-9 and tissue inhibitors of metalloproteinases-1,-2 in lung cancer - TIMP-1 as a prognostic marker [J].Anticancer Res,2000,20: 1311-1316.

共引文献51

同被引文献90

引证文献8

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部